Apellis Pharmaceuticals shares owned by Brookfield Asset Management
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Brookfield Asset Management
from 13F filings
Historical chart of Brookfield Asset Management investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Brookfield Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Apellis Pharmaceuticals by Brookfield Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-06-30 | $8.7M | 95k | 91.10 |
2023-03-31 | $7.7M | 116k | 65.96 |
2022-12-31 | $3.4M | 66k | 51.71 |
2022-09-30 | $4.1M | 60k | 68.30 |
2022-06-30 | $1.6M | 34k | 45.22 |
2022-03-31 | $755k | 15k | 50.79 |
More positions owned by Brookfield Asset Management
View all positions for Brookfield Asset Management